Share Price:

APNASPENAspen Pharmacare Hldgs169000 (0.00%)

Aspen is in a closed period from 1st July 2024 until the publication of the FY2024 results on the JSE SENS platform to be released on the 3rd September 2024.

Aspen to participate in the Investec CEO conference in London

Aspen's Stephen Saad and Sean Capazorio will take part in Investec's CEO conference in London from 14 to 15 November 2024.

Durban – JSE Limited listed Aspen Pharmacare Holdings Limited (“Aspen”) (APN:JSE), a global specialty and branded pharmaceutical company, announced today that Stephen Saad, Group Chief Executive and Sean Capazorio, Group Chief Financial Officer, are scheduled to participate in meetings with investors at the Investec CEO Conference on 14  and 15 November 2024.

 

Investors, analysts, members of the media and the general public may access the presentation on Aspen’s website which will be made available on 14 November 2024, at 08:00am GMT+2/ 06:00AM GMT +00. 

Facebook
Twitter
LinkedIn
Pinterest

Closed Period

Aspen is in a closed period from 1 January until the publication of our interim results on the JSE SENS platform scheduled to be released on 1 March 2023.

The live presentation will take place in Cape Town at 08h30 on 2 March 2023.